(Q52606443)

4 May 2018

title

Change of the melanocortin system caused by bilateral subthalamic nucleus stimulation in Parkinson's disease. (English)

1 reference

4 May 2018

1 reference

1 reference

F Escamilla-Sevilla

1

1 reference

4 May 2018

M J Pérez-Navarro

2

1 reference

4 May 2018

M Muñoz-Pasadas

3

1 reference

4 May 2018

C Sáez-Zea

4

1 reference

4 May 2018

M Jouma-Katati

5

1 reference

4 May 2018

G Piédrola-Maroto

6

1 reference

4 May 2018

A Ramírez-Navarro

7

1 reference

4 May 2018

A Mínguez-Castellanos

8

1 reference

4 May 2018

language of work or name

English

0 references

publication date

4 January 2011

1 reference

4 May 2018

Acta Neurologica Scandinavica

published in

1 reference

4 May 2018

volume

124

1 reference

4 May 2018

issue

4

1 reference

4 May 2018

page(s)

275-281

1 reference

4 May 2018

A randomized trial of deep-brain stimulation for Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Body weight gain rate in patients with Parkinson's disease and deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Anatomy and regulation of the central melanocortin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

The central melanocortin system directly controls peripheral lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Obesity and the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Leptin regulated calcium channels of neuropeptide Y and proopiomelanocortin neurons by activation of different signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Role of neuropeptides in appetite regulation and obesity--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Predictors of weight loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

The role of leptin in leptin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Weight gain following unilateral pallidotomy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Increase in body weight after pramipexole treatment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

A possible role of neuropeptide Y in depression and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Neuropathology of autonomic nervous system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

Hypocretin (orexin) cell loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2010.01469.X

10.1111/J.1600-0404.2010.01469.X

21 January 2018

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018